HEALTH

SUDBURY, Mass. — Pure Encapsulations on Thursday introduced PureHeart Probiotic, the newest addition to the PureHeart Protocol: Screening + Supplements = Success line of nutritional supplements. 

“With the proprietary probiotic strain Lactobacillus reuteri NCIMB 30242, PureHeart Probiotic offers evidence-based support from a new angle in clinical cardiology,” stated Kelly Heim, nutritional pharmacologist at Pure Encapsulations. “This exclusive formulation addresses basic aspects of lipid metabolism and vascular function.” 

NEWTON SQUARE, Pa. — Boiron on Thursday introduced a new pediatric cough-cold item to its lineup — Children’s Chestal Cold & Cough, a multi-symptom formula. The new syrup targets such symptoms of the common cold as nasal and chest congestion, cough, runny or stuffy nose, sneezing and minor sore throat. It provides parents with an option that works naturally with their little one’s bodies for children ages 3 years and older after manufacturers of antihistamines and decongestants relabeled their products for children 4 years of age and older. 

NORTH ANDOVER, Mass. — Nelsons on Thursday introduced Homeopathic H+Care Hemorrhoid Cream, a new hemorrhoid cream that provides relief from hemorrhoid pain, itching and burning without the use of vasoconstrictors. Vasoconstrictors can negatively affect other health issues like high blood pressure.

WASHINGTON — A project by the philanthropic wing of the American Pharmacists Association to include pharmacists on diabetes care teams in highly affected and underserved communities has produced significant decreases in blood-sugar levels among patients, according to results released Thursday.

PALM CITY, Fla. — GelStat Corp. on Wednesday announced that it has closed the acquisition of CBD Life Sciences.

Concurrent with the closing of the transaction, Larry Gershman has been appointed as CEO and chairman. Gerald Kieft, the company's prior CEO, will assume the position of CFO and be appointed to the board. 

NEWARK, Calif. — Drug maker Depomed has sold its interests in royalty and milestone payments for several Type 2 diabetes drugs to PDL BioPharma, Depomed said.

The drug maker announced that it had sold its interest in the Type 2 diabetes therapeutic area to PDL for $240.5 million, which it plans to use to acquire rights to products it said would drive long-term growth and build on its expertise in pain and neurology.

CHICAGO — To assist CPG manufacturers and retailers in generating new levels of growth through a better understanding of these shopper needs, Information Resources joined forces with SPINS to create SPINS NaturaLink, a new segmentation of the total U.S. population, which focuses on how shoppers think about, purchase and use natural/organic/ecofriendly products, the two firms announced Tuesday.

SLOUGH, England — Reckitt Benckiser has realized a greater value out of its 1-year-old acquisition of Schiff, which moved the consumer product goods conglomerate into the dietary supplement arena, and expects to push that VMS business to greater heights in the coming year, Rakesh Kapoor, Reckitt Benckiser CEO and executive director told analysts during a conference call Tuesday.